Fangzhou Inc. signed a Memorandum of Understanding with Novo Nordisk at the 3rd China International Supply Chain Expo in Beijing to collaborate on managing chronic diseases like diabetes and obesity. Fangzhou plans to use its AI application services and technology infrastructure to create a comprehensive health management service, shifting focus to a “health-centered” model. Both companies aim to deliver innovative digital solutions for global blood sugar and weight management. This collaboration will integrate chronic disease prevention and digital innovation technology to enhance public awareness of diabetes and obesity and support the “Healthy China 2030” strategic objectives.

Read more at GlobeNewswire: Fangzhou and Novo Nordisk Signed Collaboration Memorandum